Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model

BACKGROUND AND OBJECTIVE: In Germany, influenza vaccination is mainly advised for persons aged 60 years and over and individuals with health risks. Since 2021, an inactivated, quadrivalent high-dose influenza vaccine (IIV4-HD) has been recommended for persons aged 60 years and over. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Pahmeier, Kathrin, Speckemeier, Christian, Neusser, Silke, Wasem, Jürgen, Biermann-Stallwitz, Janine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570167/
https://www.ncbi.nlm.nih.gov/pubmed/37434014
http://dx.doi.org/10.1007/s40273-023-01299-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570167/
https://www.ncbi.nlm.nih.gov/pubmed/37434014
http://dx.doi.org/10.1007/s40273-023-01299-y

Ejemplares similares